Article
Effect of CYP3A5 and CYP3A4 Genetic Variants on Fentanyl Pharmacokinetics in a Pediatric Population.
Clinical pharmacology and therapeutics - 1 Apr 2022
Williams Michael L, Kannankeril Prince J, Breeyear Joseph H, Edwards Todd L, Van Driest Sara L, Choi Leena
Abstract excerpt
Fentanyl is an anesthetic/analgesic commonly used in surgical and recovery settings. CYP3A4 and CYP3A5 encode enzymes, which metabolize fentanyl; genetic variants in these genes impact fentanyl pharmacokinetics in adults. Pharmacokinetic (PK) studies are difficult to replicate in children due to the burden of additional blood taken solely for research purposes. The aim of this study is to test the effect of...
Topics
Join the communities discussing this publication.
